Skip to main content

Table 1 Sample information

From: Correction: High-resolution transcriptomics informs glial pathology in human temporal lobe epilepsy

Sample ID

Tissue, location

Age, Gender PMT

Nuclei RNA-SEQ

SC RNA-SEQ

Pathological diagnosis

Cell-type specific FANS Validation, TL vs. TLE

10,662

TL control, temporal lobe neocortex

34yo, M

12 h PMT

 

No neuropathological changes seen in cortex

10,355

TL control, temporal lobe neocortex

45yo, F

12 h PMT

 

No neuropathological changes seen in cortex

10,997

TL control, temporal lobe neocortex

27yo, M

21 h PMT

 

No neuropathological changes seen in cortex

12,321

TLE, temporal lobe neocortex

50yo, M

 

Cortical and Chaslin Gliosis; White matter neuronal heterotopia

10,308

TLE, temporal lobe neocortex

29yo, F

 

Cortical and Chaslin gliosis; FCD Ia

12,726

TLE, temporal lobe neocortex

13yo, M

 

Cortex without pathologic changes; *

14,431

TLE, temporal lobe neocortex

28yo, M

 

(10X, v2)

Cortical Gliosis; Ectopic white matter neurons with mild hypertrophy;

19,619

TLE, temporal lobe neocortex

31yo, F

 

(10X, v2)

Chaslin gliosis; *

20,188

TLE, temporal lobe neocortex

58yo, F

 

(10X, v3)

Cortical and Chaslin gliosis, rare neurons with hypertrophy and disoriented dendrites; *

12,814

TLE, temporal lobe neocortex

11yo, M

 

(10X, v1)

Chaslin gliosis; *

13,059

TLE, temporal lobe neocortex

8yo, M

 

(10X, v1)

Gliosis, neuronal heterotopia;

Sample ID

Tissue, location

Age, Gender

Ki-67 IF

In vitro assays

Pathological diagnosis

Phenotypic analysis of epilepsy glia

12,321

TLE, temporal lobe neocortex

50yo, M

’ (high)

Cortical and Chaslin Gliosis; White matter neuronal heterotopia;

10,308

TLE, temporal lobe neocortex

29yo, F

(low)

Cortical and Chaslin gliosis; FCD Ia;

12,726

TLE, temporal lobe neocortex

13yo, M

’ (high)

 

Cortex without pathologic changes; *

14,431

TLE, temporal lobe neocortex

28yo, M

(low)

Cortical Gliosis; Ectopic white matter neurons with mild hypertrophy;

12,319

Epilepsy, frontal lobe neocortex

27yo, M

’ (high)

 

Chaslin Gliosis; Ischemic changes

12,433

Epilepsy, TS, frontal lobe neocortex

4yo, M

(low)

Cortical and Chaslin Gliosis; **

  1. PMT Postmortem time, IF Immunofluorescence, M Male, F Female, yo years old; h hours; TS Tuberous sclerosis. FCD Focal cortical dysplasia
  2. *Hippocampal sclerosis seen away from the sampled area, **Tubers seen away from the sampled area.’ Samples included in the IF analysis of Ki67 proliferation cell type distribution